RSS Feed
November 24th, 2020 
Awake Goy 
Scientists in the UK are starting trials of a cocktail of antibody drugs that they hope will help treat people with symptoms of COVID-19. The mix, developed by Regeneron Pharmaceuticals, is to be given to people who have the infection and are at high risk. Experts say demand is expected to outstrip supply.
Dr. Rafael Mañez Mendiluce is the Director of the Intensive Care Department at the University Hospital in Barcelona. He says as there are no treatments, any new therapies for COVID-19 patients will be very welcome.
Watch Euronews’ interview with Dr. Rafael Mañez Mendiluce in the media player above.
Related posts:
COVID CONUNDRUM
COVID CLAIMS - UPDATES
58 People Were Killed In Las Vegas, We Still Don’t Know Why Or How, And Nobody Cares
Pfizer plans to hike price of covid jabs by 10,000% next year to fund other drugs; calls scamdemic a...
Facts Matter (Nov. 1): Study Finds Vaccinated People Just as Likely to Spread Delta Within Household
EUGENICS: British Spy Chief Confesses – ‘COVID Was Engineered To Depopulate The Planet’
Posted in 
Tags: 
